Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (784)	5/8/1998 10:16:00 AM
From: InvestorLady	Read Replies (2) \| Respond to of 1491

Great stuff Ariella, thanks. The risks seem to be the added dilution over the last year and future dilution as they are underfunded, phase II and III results as they are not known yet and the acceptance of new products into the market place (great promise, not proven...yet). That B score from your posts lends for pretty good risk/reward ratio. Thanks for taking the time to research and posts that! Head trauma and stroke damage are so important to reduce. I have seen a person have a stroke and it is beyond sad-- none of us knew what was happening. With education and better drugs perhaps this relative would be enjoying a better quality of life today. Since we are living longer the risk of stroke is higher and this is one reason I am in this stock: the market demand for their current and future products in testing is increasing. You are correct, they need to practice up for future PR demands..:) Hopefully, they will take this to heart and be well prepared. Lady